Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

53 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinical outcomes and toxicity after exclusive versus postoperative radiotherapy in supraglottic cancer: new solutions for old problems? The case of stage III and IV disease.
Costa L, Pedretti S, Foscarini F, Maddalo M, Pegurri L, Pasinetti N, Cavagnini R, Ciccarelli S, Tonoli S, Magrini SM, Buglione M. Costa L, et al. Among authors: maddalo m. Radiol Med. 2016 Jan;121(1):70-9. doi: 10.1007/s11547-015-0565-6. Epub 2015 Aug 1. Radiol Med. 2016. PMID: 26231252
Oral toxicity management in head and neck cancer patients treated with chemotherapy and radiation: Dental pathologies and osteoradionecrosis (Part 1) literature review and consensus statement.
Buglione M, Cavagnini R, Di Rosario F, Sottocornola L, Maddalo M, Vassalli L, Grisanti S, Salgarello S, Orlandi E, Paganelli C, Majorana A, Gastaldi G, Bossi P, Berruti A, Pavanato G, Nicolai P, Maroldi R, Barasch A, Russi EG, Raber-Durlacher J, Murphy B, Magrini SM. Buglione M, et al. Among authors: maddalo m. Crit Rev Oncol Hematol. 2016 Jan;97:131-42. doi: 10.1016/j.critrevonc.2015.08.010. Epub 2015 Aug 12. Crit Rev Oncol Hematol. 2016. PMID: 26318095 Review.
Cetuximab and Radiotherapy Versus Cisplatin and Radiotherapy for Locally Advanced Head and Neck Cancer: A Randomized Phase II Trial.
Magrini SM, Buglione M, Corvò R, Pirtoli L, Paiar F, Ponticelli P, Petrucci A, Bacigalupo A, Crociani M, Lastrucci L, Vecchio S, Bonomo P, Pasinetti N, Triggiani L, Cavagnini R, Costa L, Tonoli S, Maddalo M, Grisanti S. Magrini SM, et al. Among authors: maddalo m. J Clin Oncol. 2016 Feb 10;34(5):427-35. doi: 10.1200/JCO.2015.63.1671. Epub 2015 Dec 7. J Clin Oncol. 2016. PMID: 26644536 Clinical Trial.
Oral toxicity management in head and neck cancer patients treated with chemotherapy and radiation: Xerostomia and trismus (Part 2). Literature review and consensus statement.
Buglione M, Cavagnini R, Di Rosario F, Maddalo M, Vassalli L, Grisanti S, Salgarello S, Orlandi E, Bossi P, Majorana A, Gastaldi G, Berruti A, Trippa F, Nicolai P, Barasch A, Russi EG, Raber-Durlacher J, Murphy B, Magrini SM. Buglione M, et al. Among authors: maddalo m. Crit Rev Oncol Hematol. 2016 Jun;102:47-54. doi: 10.1016/j.critrevonc.2016.03.012. Epub 2016 Mar 11. Crit Rev Oncol Hematol. 2016. PMID: 27061883 Review.
Resected pN1 non-small cell lung cancer: recurrence patterns and nodal risk factors may suggest selection criteria for post-operative radiotherapy.
Borghetti P, Barbera F, Bonù ML, Trevisan F, Ciccarelli S, Vitali P, Maddalo M, Triggiani L, Pasinetti N, Pedretti S, Bonetti B, Pariscenti G, Tironi A, Caprioli A, Buglione M, Magrini SM. Borghetti P, et al. Among authors: maddalo m. Radiol Med. 2016 Sep;121(9):696-703. doi: 10.1007/s11547-016-0648-z. Epub 2016 May 26. Radiol Med. 2016. PMID: 27230669
53 results